Figure 2
From: Different clinical patterns of IgG4-RD patients with and without eosinophilia
Changes in peripheral blood eosinophil (PBE) counts during follow-up, grouped according to treatment options. (A–D) display peripheral blood eosinophil counts at baseline, the third month follow-up, the sixth-month follow-up, and the 12th month follow-up, respectively. Bars represent median and interquartile ranges. GC mono, glucocorticoids monotherapy; GC & IM, combination therapy with glucocorticoids and immunosuppressants; IM mono, immunosuppressants monotherapy.
